投資評等
最後更新日期：2024/11/23
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2013/10/31 | Argus | Hold >> Buy | 49 |
| 2012/8/15 | Standpoint Research | Hold >> Buy | 33 |
| 2011/8/8 | Standpoint Research | Hold >> Buy | 33 |
| 2010/2/5 | Deutsche Bank | Hold >> Buy | 35 |
| 2010/1/20 | Citigroup | Hold >> Buy | $33 >> $37 |
| 2009/9/30 | BMO Capital Markets | Market Perform >> Outperform | |
| 2009/5/22 | Citigroup | Sell >> Hold | |
| 2007/7/2 | Banc of America Sec | Neutral Buy | |
| 2006/6/9 | Prudential | Neutral Overweight | |
| 2005/9/27 | Prudential | Neutral->Overweight | |
| 2005/8/22 | Citigroup | Hold->Buy | |
| 2005/1/31 | Smith Barney Citigroup | Sell->Hold | |
| 2004/11/15 | CSFB | Neutral->Outperform | 25 |
| 2004/10/26 | CSFB | Underperform->Neutral | |
| 2004/10/1 | FTN Midwest | Sell->Neutral | |
| 2003/3/18 | Banc of America Sec | Sell -> Neutral | 10 |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/12/4 | Miller Tabak | Buy >> Hold | 53 |
| 2012/5/1 | Standpoint Research | Buy >> Hold | |
| 2010/9/14 | Stanford Research | Buy >> Hold | |
| 2009/8/5 | Oppenheimer | Outperform >> Perform | |
| 2009/4/8 | Soleil | Buy Sell | |
| 2009/4/7 | Citigroup | Hold Sell | |
| 2005/8/1 | CSFB | Outperform->Neutral | 25 |
| 2005/4/6 | FTN Midwest | Neutral->Sell | |
| 2005/2/23 | Merrill Lynch | Buy->Neutral | |
| 2004/12/6 | Prudential | Overweight->Neutral | |
| 2003/9/3 | CSFB | Neutral -> Underperform | |
| 2002/12/11 | Banc of America Sec | Mk -> Rerform -> Underperform | |
| 2002/8/27 | Salomon Smth Brny | Buy -> Neutral | 15.5 |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2013/12/24 | Stifel | Hold | |
| 2011/11/7 | Ticonderoga | Neutral | |
| 2011/8/23 | Barclays Capital | Equal Weight | 31 |
| 2011/3/22 | Stifel Nicolaus | Buy | 44 |
| 2010/12/16 | Jefferies | Hold | 34 |
| 2007/4/24 | Banc of America Sec | Neutral | 40 |
| 2007/4/24 | JP Morgan | Overweight | |
| 2004/10/14 | Harris Nesbitt | Neutral | |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 查無資料 | | | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2014/8/20 | Argus | Buy | $49 >> $57 |
| 2005/10/12 | Prudential | Overweight | 27 |
| 2005/8/1 | Prudential | Neutral | 20 |
| 2005/2/23 | Deutsche Securities | Buy | 25 |
| 2005/1/28 | Prudential | Neutral | 22 |
| 2005/1/19 | Harris Nesbitt | Neutral | 19 |